Galmed Pharmaceuticals Ltd. Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASD

On Thursday morning, 1178 companies hit new 52-week lows. Facts of Interest: The largest company by market cap to set a new 52-week low was Nuveen Preferred & Income...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Akero Therapeutics (AKRO) and Blueprint Medicines (BPMC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Akero Therapeutics ( AKRO – Research Report ) and Blueprint Medicines ( BPMC – Research Report ) wi

B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Galmed Pharmaceuticals (GLMD) on March 13 and set a price target of $11.00. The company's

B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Galmed Pharmaceuticals (GLMD – Research Report) on March 13 and

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galmed Pharmaceuticals (GLMD) and MyoKardia (MYOK) with

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galmed Pharmaceuticals ( GLMD – Research Report ) and MyoKardia ( MYOK – Research Report ) with bul

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sientra (SIEN), Nabriva (NBRV) and Galmed Pharmaceuticals

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sientra ( SIEN – Research Report ), Nabriva ( NBRV – Research Report ) and Galmed Pharmaceuticals (

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, curre

Companies Reporting Before The Bell Dollar General Corporation (NYSE: DG ) is projected to report quarterly earnings at $2.02 per share on revenue of $7.15 billion. Genesco Inc. (NYSE: GCO ) is estima